Zobrazeno 1 - 10
of 128
pro vyhledávání: '"D. Tinkelman"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Tinkelman
Publikováno v:
Research in Immunology. 149:197-200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::331554e849e059b05e4e6ffe24ae350d
https://doi.org/10.1016/s0923-2494(98)80030-8
https://doi.org/10.1016/s0923-2494(98)80030-8
Publikováno v:
Value in Health. 11(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44df38057b35c54982a159ffd60b0fed
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 74(3)
Compliance with an allergy immunotherapy regimen is obviously the difference between a potentially successful or unsuccessful outcome.The purpose of this study was to assess retrospectively compliance of patients receiving immunotherapy in a private
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::328520d82231292d94f341cda00678f0
https://pubmed.ncbi.nlm.nih.gov/7552935
https://pubmed.ncbi.nlm.nih.gov/7552935
Autor:
D. Tinkelman, R. Dockhorn, J. Grossman, C. Banov, P. B. Boggs, J. W. Georgitis, Paul Roszko, Chester C. Wood
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 24(11)
Intranasal fluorocarbon anticholinergic agents have been used to treat the nasal hypersecretion of perennial non-allergic rhinitis, but chronic use has been restricted either due to the potential for systemic anticholinergic adverse events or due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dafa94080a051c481a41af392a6fcc6
https://pubmed.ncbi.nlm.nih.gov/7874603
https://pubmed.ncbi.nlm.nih.gov/7874603
Autor:
W, Storms, E, Bronsky, S, Findlay, D, Pearlman, S, Rosenberg, G, Shapiro, L, Southern, D, Tinkelman, S, Weakley, M, Welch
Publikováno v:
Annals of allergy. 66(4)
A randomized, double-blind, placebo-controlled, parallel group study was conducted in 11 centers to evaluate the safety and efficacy of a once-a-day regimen of 110 micrograms, 220 micrograms; and 440 micrograms of triamcinolone acetonide intranasal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57e02ec388020314451442fd913d4601
https://pubmed.ncbi.nlm.nih.gov/2014934
https://pubmed.ncbi.nlm.nih.gov/2014934
Autor:
S, Spector, E, Bronsky, P, Chervinsky, G, Lotner, J, Koepke, J, Selner, D, Pearlman, D, Tinkelman, S, Weakley, V, Alderfer
Publikováno v:
Annals of allergy. 64(3)
In a double-blind study involving 205 patients with perennial allergic rhinitis, statistically significantly greater symptomatic improvements were evident following the administration of 200 micrograms/day triamcinolone acetonide aerosol than followi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3328362464da361a34d869ddd473d5c
https://pubmed.ncbi.nlm.nih.gov/2178497
https://pubmed.ncbi.nlm.nih.gov/2178497
Autor:
D, Tinkelman, C, Falliers, G, Gross, A, Segal, L, Southern, M, Welch, H, Yeates, J, Gorder, J, Garcia
Publikováno v:
Annals of allergy. 64(2 Pt 2)
Triamcinolone acetonide aerosol inhalation therapy is effective for the prophylactic treatment of asthma. Recently, the delivery system for this preparation has been modified for use in allergic rhinitis. A total of 180 adult patients with symptomati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0843cffdde1cbe29c8cdfa456c13e2fa
https://pubmed.ncbi.nlm.nih.gov/2405747
https://pubmed.ncbi.nlm.nih.gov/2405747